Adjuvant Treatment in Non-Small Cell Lung Cancer: Where Are We Now?

Author： Juergens Rosalyn A.   Brahmer Julie R.  

Publisher： Cambridge Scholars Publishing in association with GSE Research

ISSN： 1540-1405

Source： Journal of the National Comprehensive Cancer Network (JNCCN), Vol.4, Iss.6, 2006-07, pp. : 595-600

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pemetrexed for the treatment of non-small cell lung cancer

By Genova Carlo  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 11, 2013-08 ,pp. : 1545-1558

Informa Healthcare

Access to resources Recommend Favorite

Vinorelbine in the Treatment of Non-Small Cell Lung Cancer

By  

Current Medicinal Chemistry, Vol. 9, Iss. 8, 2002-04 ,pp. : 879-891

Bentham Science Publishers

Access to resources Recommend Favorite

Resectable Non-Small Cell Lung Cancer in the Elderly: Is There a Role for Adjuvant Treatment?

By Langer Corey J.  

Drugs & Aging, Vol. 25, Iss. 3, 2008-01 ,pp. : 209-218

Adis International

Access to resources Recommend Favorite

Pemetrexed: Potential Role in the Adjuvant Chemotherapy of Non-Small Cell Lung Cancer

By  

Current Drug Targets, Vol. 11, Iss. 1, 2010-01 ,pp. : 78-84

Bentham Science Publishers

Access to resources Recommend Favorite

Non–Small Cell Lung Cancer

By  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 3, 2008-03 ,pp. : 228-228

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite